Showing 11 results

Filters Content type: Editors' picks Conference: CROI 2011
New & experimental HIV treatments

What Lies Ahead: An Activist's View of Promising HIV Treatment Research

Editor's pick
The Body
31 March 2011
How HIV works

Malaria Drug Plaquenil Calms Immune Activation

Editor's pick
AIDSMeds
9 March 2011
Treatment outcomes & life expectancy

CD4s, Viral Load Not Enough to Predict Survival During HIV Treatment

Editor's pick
AIDSMeds
8 March 2011
Ageing & HIV

Aging and HIV: Older HIV-Positive Men Are Frailer Than Similar HIV-Negative Men

Editor's pick
AIDSMeds
7 March 2011
New & experimental HIV treatments

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Editor's pick
The Medical News
3 March 2011
New & experimental HIV treatments

Virostatics' VS411 Phase 2a trial results against HIV presented at 18th CROI

Editor's pick
The Medical News
2 March 2011
New & experimental HIV treatments

Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells In Gut Mucosa Of Chronically HIV Infected Immunological Non-Responder Patients

Editor's pick
HIV / AIDS News From Medical News Today
2 March 2011
Neurological & cognitive problems

Previous Syphilis Infection Might Cause Poorer Brain Function for People With HIV

Editor's pick
AIDSmeds.com
1 March 2011
Treatment for women

Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

Editor's pick
The BodyPro
1 March 2011
Starting treatment

3-year results on Merck’s ISENTRESS® (raltegravir): sustained viral load suppression and tolerability

Editor's pick
Business Week
1 March 2011
Treatment outcomes & life expectancy

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
AIDSMeds
1 March 2011